Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leukemia, Plasma Cell × incomplete Freund's adjuvant × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1 Leukemia, Plasma Cell 1

Interventions

sargramostim 1 montanide ISA 51 1 itacitinib 1 incomplete Freund's adjuvant 1 Lenalidomide 1 High-Throughput Screening Assays 1 Colony-Stimulating Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334865 2025-05-11

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Roswell Park Cancer Institute

Phase 1 Active not recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡